FDA Approves First Cannabis-Derived Drug

July 6, 2018 in Marijuana Regulatory Law by walsh.law

On June 25, 2018, the FDA approved marijuana based Epidiolex, a drug targeting severe forms of epilepsy. Whereas other synthetic marijuana drugs are already on the market, Epidiolex marks the first cannabis plant derivative to receive FDA approval. Although marijuana remains a Schedule I substance...

Walsh’s Second Anniversary Clothing Drive a Success!

June 14, 2018 in Firm News by walsh.law

Walsh Pizzi O’Reilly Falanga LLP celebrated its second anniversary during the month of May by holding a clothing drive. Christine I. Gannon, the attorney coordinating the project, explained:  “Since the traditional second-anniversary gift is cotton, the firm collected business wear to benefit Dress for Success® and Career Gear®,...

The Crapo Bill Rolls Back Certain Dodd-Frank Regulations

June 14, 2018 in Finance Law by walsh.law

By: Colleen M. Maker On May 24, 2018, President Trump signed the Economic Growth, Regulatory Relief, and Consumer Protection Act, known as the Crapo Bill after its Senate sponsor, which rolls back portions of the 2010 Dodd-Frank Wall Street Reform and Consumer Protection Act (“Dodd-Frank”). Dodd-Frank was...